17-Phenyl trinor prostaglandin E2 ethyl amide  (Synonyms: 17-Phenyl trinor PGE2 ethyl amide)

17-Phenyl trinor prostaglandin E2 ethyl amide (17-Phenyl trinor PGE2 ethyl amide) is a EP1 receptor agonist. 17-Phenyl trinor prostaglandin E2 ethyl amide aggravates renal dysfunction and glomerulosclerosis^[1].

17-Phenyl trinor prostaglandin E2 ethyl amide (0.3 µg/g; i.p.; three times a week for 12 weeks) aggravates renal dysfunction and glomerulosclerosis in five‑sixths nephrectomy renal fibrosis model mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

413.55

C₂₅H₃₅NO₄

1219032-20-8

O[C@@H](CCC1=CC=CC=C1)/C=C/[C@@H]2[C@H](C(C[C@H]2O)=O)C/C=C\CCCC(NCC)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Chen X, et al. Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis. Mol Med Rep. 2020 Oct;22(4):2887-2895.  [Content Brief]